KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Invested Capital (2016 - 2025)

Eli Lilly (LLY) has disclosed Return on Invested Capital for 17 consecutive years, with 0.5% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 16.0% year-over-year to 0.5%, compared with a TTM value of 0.5% through Dec 2025, down 16.0%, and an annual FY2025 reading of 0.43%, down 2.0% over the prior year.
  • Return on Invested Capital was 0.5% for Q4 2025 at Eli Lilly, down from 0.73% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 5.99% in Q3 2024 and bottomed at 1.82% in Q2 2021.
  • Average Return on Invested Capital over 5 years is 0.96%, with a median of 0.66% recorded in 2024.
  • The sharpest move saw Return on Invested Capital skyrocketed 568bps in 2024, then plummeted -526bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.44% in 2021, then skyrocketed by 158bps to 1.14% in 2022, then plummeted by -66bps to 0.39% in 2023, then skyrocketed by 72bps to 0.67% in 2024, then decreased by -24bps to 0.5% in 2025.
  • Business Quant data shows Return on Invested Capital for LLY at 0.5% in Q4 2025, 0.73% in Q3 2025, and 0.88% in Q2 2025.